How Does Adefovir Work? Mechanism of Action Explained in Plain English

Adefovir dipivoxil is a powerful antiviral medication for hepatitis B, but how exactly does it stop the hepatitis B virus? Understanding the mechanism of action can help you feel more confident in your treatment. This guide breaks it down in plain language — no medical degree required.

First: How Does the Hepatitis B Virus Replicate?

To understand how adefovir works, you first need to understand how the hepatitis B virus (HBV) makes copies of itself. HBV is a DNA virus, but it has an unusual replication cycle:

HBV enters a liver cell (hepatocyte) and travels to the nucleus

Inside the nucleus, it forms covalently closed circular DNA (cccDNA) — a stable template that persists in the cell

The cccDNA is used to produce messenger RNA (mRNA), which includes pregenomic RNA

The pregenomic RNA is then reverse-transcribed back into HBV DNA by an enzyme called HBV DNA polymerase (which acts as a reverse transcriptase)

This new HBV DNA is packaged into viral particles and released from the liver cell to infect more cells

The key step that adefovir disrupts is Step 4 — the reverse transcription process.

How Adefovir Disrupts HBV Replication

Adefovir is a prodrug — meaning it is an inactive compound that the body converts into the active drug. Here is how it works:

Step 1 — Activation: After you swallow an adefovir dipivoxil tablet, it is absorbed and converted by enzymes in the body to adefovir, the active compound. Adefovir is then phosphorylated (has phosphate groups added) inside cells to form the active metabolite called adefovir diphosphate.

Step 2 — Competing with natural building blocks: Adefovir diphosphate is structurally similar to deoxyadenosine triphosphate (dATP) — one of the natural building blocks of DNA. When HBV DNA polymerase is building a new strand of viral DNA, it can mistake adefovir diphosphate for the real dATP.

Step 3 — Chain termination: When adefovir diphosphate is incorporated into the growing viral DNA chain, it acts as a chain terminator. Unlike the natural dATP, adefovir diphosphate lacks the specific chemical structure needed to continue building the DNA chain. The viral DNA chain stops growing at that point.

Result: New HBV DNA copies cannot be completed. Viral replication is halted. The virus can no longer make functional new particles to infect more liver cells.

Why Adefovir Is Selective for HBV

One of adefovir's important properties is that it inhibits HBV DNA polymerase at concentrations much lower than those needed to inhibit human DNA polymerases. This selectivity means it targets the virus while largely sparing human cells — though not perfectly, which is why kidney monitoring is still required.

Why Doesn't Adefovir Cure Hepatitis B?

Adefovir suppresses HBV replication but does not eliminate the cccDNA reservoir in the nucleus of infected liver cells. As long as cccDNA persists, the virus can restart replication when medication is stopped. This is why:

Adefovir is a lifelong treatment for most patients (until criteria for stopping are met)

Stopping abruptly causes viral rebound and hepatitis flares

The goal is viral suppression (undetectable HBV DNA), not viral elimination

39,333+ patients found their medications in stock

39K+

Find Adefovir In Stock Today →

Why Adefovir Has a Low Genetic Barrier to Resistance

Over time, HBV can develop mutations in its DNA polymerase gene that reduce adefovir's effectiveness. The specific resistance mutations for adefovir (rtA181T/V and rtN236T) can emerge, especially when the virus is not fully suppressed. This is why your doctor monitors HBV DNA levels regularly and may consider switching to a more potent agent if levels are not adequately suppressed.

Having trouble filling your adefovir prescription? medfinder locates pharmacies with it in stock near you. Also read: What Is Adefovir? Uses, Dosage, and What You Need to Know